IJMM International Journal of Molecular Medicine 1107-3756 1791-244X D.A. Spandidos 10.3892/ijmm.2012.1157 ijmm-30-06-1349 Articles Centella asiatica protects against UVB-induced HaCaT keratinocyte damage through microRNA expression changes ANIN-SOOK1* ANSUNGKWAN12* CHOETAE-BOO3 KANGSANG-MO3 LEEJAE HO4 PARKIN-CHUL5 JINYOUNG-WOO6 LEESU-JAE7 BAESEUNGHEE2 Korea Institute for Skin and Clinical Sciences Molecular-Targeted Drug Research Center and Department of Microbial Engineering, Konkuk University, Seoul 143-701; Laboratory of Molecular Oncology, Cheil General Hospital and Women’s Healthcare Center, Kwandong University, College of Medicine, Seoul 100-380; Laboratory of Functional Genomics, Korea Institute of Radiological and Medical Sciences, Seoul 139-706; Division of Radiation Effect Research, Radiation Health Research Institute of KHNP, Seoul 132-703; Department of Chemistry, Hanyang University, Seoul 133-791, Republic of Korea Correspondence to: Dr Seunghee Bae, Molecular-Targeted Drug Research Center, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul 143-701, Republic of Korea, E-mail: sbae@konkuk.ac.kr

Contributed equally

 15 10 2012 12 2012 30 6 1349 1356 07 06 2012 10 09 2012 Copyright © 2012, Spandidos Publications 2012

This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.

This study aimed to evaluate the protective effects of Centella asiatica (C. asiatica) against ultraviolet B (UVB) damage in human keratinocytes using microRNA (miRNA) expression profiling analysis. Titrated extract of C. asiatica (TECA) demonstrated low cytotoxicity in normal human HaCaT keratinocytes only at low doses (<5 μg/ml). UVB (50 mJ/cm2) irradiation significantly decreased cell viability, and TECA treatment decreased the UVB toxicity. By using miRNA microarrays, we determined that 72 miRNAs had an altered expression following TECA treatment in UVB-irradiated keratinocytes (46 upregulated and 26 down-regulated). Using an miRNA target gene prediction tool and Gene Ontology (GO) analysis, we determined that miRNAs with altered expression were functionally related with the inhibition of apoptosis and cell proliferation. Overall, these results provide meaningful information to facilitate the understanding of TECA-mediated UVB protection in human keratinocytes.

 Centella asiatica keratinocyte ultraviolet B miRNA expression cell viability Introduction

UV irradiation leads to cell aging, senescence, apoptosis and cancer in human keratinocytes by inducing reactive oxygen species (ROS), DNA damage and inflammatory and immunological reactions (1). Members of the mitogen-activated protein kinase (MAPK) family, including ERK1/2, p38 MAPK and JNK, are phosphorylated (activated) by UV irradiation (1). A low-dose of UVB (ultraviolet B) (0.1 kJ/cm2) significantly produces tumor necrosis factor α (TNF-α), which is involved in the suppression of contact hypersensitivity and in the decreased immunosurveillance in UV-damaged keratinocytes (2). In addition, the protein half-life of nuclear factor-κB (NF-κB) is prolonged by the inhibitor of NF-κBα (IκBα) phosphorylation and proteasomal degradation, and activated NF-κB may induce both anti- and pro-apoptotic pathways (3–7). Furthermore, UVB irradiation induces cytokine IL-21 and nitric oxide (NO), which are closely related to keratinocyte immune responses (8,9). Collectively, UVB irradiation activates multiple signaling cascades in keratinocytes.

microRNAs (miRNAs) are small, non-coding RNA molecules that directly regulate the expression of target mRNA transcripts (10). miRNAs have been reported to be involved in almost all cellular processes, including development, proliferation, immune response, metabolism and cell death (11–13). In human skin, miRNA-based studies first investigated miRNA expression patterns in normal human skin and melanocytic nevi (14,15). A functional relationship between keratinocyte miRNAs and psoriasis was reported, and it was determined that miR-125b modulates abnormal keratinocyte proliferation in psoriasis by targeting FGFR2 (16,17). The miRNA expression pattern during human keratinocyte differentiation has also been investigated (18). One recent study analyzed UVB-dependent miRNA expression profile changes in keratinocytes (19). Overall, these reports indicate that miRNAs may be key regulators of multiple cellular processes in keratinocytes and further suggest that miRNAs may have protective functions in response to UVB.

Centella asiatica (C. asiatica, also known as gotu kola) is a plant used in traditional herbal medicine with pharmacological effects on skin wound healing (20,21). It also shows anti-oxidant, anti-microbial and anticancer properties (22,23). We demonstrated that H2O2-induced cell senescence was inhibited by treating human dermal fibroblasts with a titrated extract of C. asiatica (TECA) (24). Although there was a recent report regarding the UVB protective effect of TECA treatment on dermal fibroblasts (25), the molecular mechanisms of UV protection have not been elucidated. Furthermore, a possible UV protective effect on human keratinocytes has not been studied. In this current study, we demonstrate that TECA exerts novel UVB protection in human keratinocytes and characterized miRNA expression profiles that correspond to TECA-mediated UVB protection.

 Materials and methods Cell culture

Normal human HaCaT keratinocytes were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Gibco-Invitrogen Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO, USA) with penicillin/streptomycin.

 UVB irradiation and TECA treatment

A day before UVB irradiation, HaCaT cells (4×103) were seeded into 96-well plates. For RNA purification, 7×105 cells were seeded into 60-mm dishes. Before UVB irradiation, cells were pre-treated with the control dimethyl sulfoxide (DMSO; Sigma-Aldrich) or TECA (Bayer Health Care, Berlin, Germany) for 3 h. Cells were washed with phosphate-buffered saline (PBS) and exposed to 50 mJ/cm2 UVB without dish covers. After irradiation, the cells were cultured in DMEM media containing 10% FBS with DMSO or TECA for 24 h.

 RNA purification and qualification

Total RNA was extracted and purified with TRIzol reagent (Invitrogen Life Technologies) according to the manufacturer’s instructions. The integrity of each RNA sample was verified with an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). The quality and concentration of each RNA sample were determined using MaestroNano (Maestrogen, Las Vegas, NV, USA). RNA quality parameters for miRNA microarray analysis were A260/280 and A260/A230 values >1.8 and an RNA integrity no. (RIN) >8.0.

 Microarray analysis of miRNA profiles

The miRNA profiling analysis was performed using SurePrint G3 Human V16 miRNA 8 × 60K (Agilent Technologies) containing a probe for 1,205 and 144 human viral miRNAs. Each qualified RNA sample (100 ng) was dephosphorylated with calf intestinal alkaline phosphatase (CIP) at 37°C for 30 min. Then, the dephosphorylated RNA samples were labeled with cyanine 3-pCp using T4 RNA ligase by incubating at 16°C for 2 h. After the labeling reaction, the samples were completely dried using a vacuum concentrator at 55°C for 4 h. The dried samples were treated with GE Blocking Agent (Agilent Technologies) and hybridized to the probes on the microarray at 55°C, at 20 rpm in the Agilent Microarray Hybridization Chamber (Agilent Technologies) for 20 h. The microarray slide was washed and scanned with the Agilent scanner to obtain the microarray image. The numerical data for the miRNA profiles were extracted from the image with the Feature Extraction program (Agilent Technologies). These data were analyzed with GeneSpring GX software version 7.3 (Agilent Technologies). miRNAs whose flags were present in at least one sample were filtered and applied to the fold-change analysis, which was conducted by a factor of 1.5-fold between two groups: UVB-exposed/DMSO-treated control and UVB-exposed/2 μg/ml TECA-treated HaCaT keratinocytes.

 Bioinformatical analysis of miRNAs

Meaningful altered miRNAs were selected, and their putative cellular target genes were determined using MicroCosm Target version 5 (www.ebi.ac.uk/enright-srv/microcosm/thdoc/targets/v5/). The target genes were categorized into four groups (aging, apoptosis, cell proliferation and skin development) using the Gene Ontology (GO) analysis tool AmiGO (amigo.geneontology.org/cgi-bin/amigo/browse.cgi). Further GO analysis was performed for several categories, such as anti-apoptosis, MAPKK activity, Ras protein signal transduction, small GTPase-mediated signal transduction, positive or negative regulation of cell growth, cell proliferation, cell cycle, immune response and positive regulation of p53-mediated signaling.

 Results TECA protects HaCaT cells against UVB damage

We first assessed the cytotoxicity of TECA. HaCaT cells were treated with increasing doses of TECA (1, 2, 5, 10 or 20 μg/ml) for 24 h, and the WST-1-based cellular toxicity assay was used to determine cell viability. As shown in Fig. 1A, low doses (up to 5 μg/ml) of TECA had no significant cytotoxic effect on HaCaT cells, while higher doses (10 and 20 μg/ml) were more cytotoxic. Based on these results, we used 1, 2 and 5 μg/ml treatments in further experiments. Next, the protective activity of TECA on keratinocytes was determined. HaCaT cells pre-treated with TECA were exposed to 50 mJ/cm2 of UVB without any protective covers. After UVB-irradiation, the cells were incubated with the indicated doses of TECA for 24 h. The WST-1 assay showed that the irradiated cells without TECA displayed a 43.52% cell survival rate, compared to non-irradiated control cells and TECA treatment (2 μg/ml) markedly improved the cell survival rate to 71.25% (Fig. 1B). Overall, TECA prevented UVB-mediated keratinocyte cell death.

 TECA alters miRNA expression profiles in UVB-treated keratinocytes

We further determined the protective effect of TECA with a miRNA expression profiling analysis and observed different miRNA expression patterns in response to TECA treatment in UVB-irradiated HaCaT cells. As shown in Fig. 2A, 72 human miRNAs were altered >1.5-fold in the TECA-treated, UVB-irradiated HaCaT cells, compared to those that were only exposed to UVB. The full list of 72 miRNAs is shown in Table I. TECA treatment affected miRNA expression levels, but the fold change was not >4.0. Among the altered miRNAs, 46 miRNAs were upregulated after TECA treatment and 26 miRNAs were downregulated (Fig. 2B). However, the extent of changes varied among miRNAs; the expression levels of miR-636, miR-3620 and miR-296-5p were significantly increased by 3.51-, 3.60- and 2.54-fold, respectively, whereas the expression of miR-622 and miR-455-5p was significantly decreased by 2.82- and 2.07-fold, respectively. Overall, TECA treatment influenced certain miRNA expression levels, suggesting that specific cellular response mechanisms may be involved in TECA-mediated UVB protection of keratinocytes.

 Bioinformatical analysis of TECA-specific miRNAs and their putative targets

We next assessed the biological meaning of the altered miRNA expression in UVB protection. miRNAs post-transcriptionally regulate gene expression by binding to target mRNAs, indicating that the biological functions of miRNAs are dependent on that of their target genes (26).

First, we analyzed the putative target genes of miRNAs that were meaningfully altered by TECA treatment using the miRNA target prediction bioinformatical tool MicroCosm. We observed that 1,354 and 1,975 genes were putatively targeted by the upregulated and downregulated miRNAs, respectively (p<0.05, data not shown). We next analyzed the biological functions for each target gene with the GO analytical tool AmiGO. Since UV irradiation induces cell aging and apoptosis (1), we sorted the target genes into several categories, including aging, apoptosis, cell proliferation and skin development (Tables II and III). We revealed that a number of target genes were involved in these four processes, suggesting that the effects of TECA may be functionally related to UV protective properties by affecting the protein products of those genes. For example, miR-636, which was increased by 3.51-fold by TECA, putatively targets genes such as suppressor of cytokine signaling 3 (SOCS3), microphthalmia-associated transcription factor (MITF), empty spiracles homeobox 2 (EMX2) and transcription factor 7-like 2 (TCF7L2). Conversely, miR-622 was decreased by 2.82-fold by TECA and putatively targets genes included nucleophosmin (NPM1), E2F transcription factor 1 (E2F1) and peroxisome proliferator-activated receptor δ (PPARD).

In keratinocytes, UV irradiation induces several molecular responses, such as pro-apoptotic signaling pathways; Ras-, MAPK- and small GTPase-mediated signal transduction and immune responses (1). We re-sorted the target genes in Tables II and III into categories of molecular responses. As shown in Fig. 3, the miRNA target genes were highly involved in these types of responses. However, the level of involvement varied. The majority of target genes was functionally related to anti-apoptosis and cell proliferation regulation, whereas a limited number of target genes was related to MAPKK activity. Collectively, these findings suggest that TECA-mediated UV protective properties may regulate molecular interplay between miRNAs and their target genes to influence apoptosis and cell proliferation.

 Discussion

In the present study, we verified that C. asiatica protects keratinocytes against UVB-induced damage. WST-1 assays demonstrated that C. asiatica-induced effects were dose-dependent. Low-doses of TECA induced proliferation, while high-doses of TECA induced cell death, indicating that C. asiatica has a dichotomous role in cell growth. The medical and pharmaceutical uses of C. asiatica are diverse. In human dermal fibroblasts, C. asiatica induces cell proliferation, collagen synthesis and anti-senescence (24,27). Additionally, C. asiatica induced gastric ulcers and promoted epithelial cell proliferation in rats (28). However, C. asiatica has also shown anti-proliferative properties in solid cancers, such as melanoma, breast, liver and gastric cancers, as well as in keratinocytes (29–33). An anti-proliferative effect on keratinocytes was shown to be highest following treatment with 18.4±0.6 μg/ml C. asiatica extract (33). We determined that >10 μg/ml of TECA was anti-proliferative, however, the lower doses of TECA (<5 μg/ml) led to increased cell proliferation. This was recently confirmed by another group, which demonstrated that C. asiatica has concentration-dependent, reciprocal proliferative effects (34).

Hashim et al (25) reported that C. asiatica protects against UVB damage in human dermal fibroblasts. However, we demonstrated that the protective effects also extended to keratinocytes and investigated the impact on miRNA. Although protecting keratinocytes from UVB-induced damage has been widely researched using other molecules and gene-based molecular studies, a limited number of miRNA-based molecular studies have been undertaken. Recently, p63-miRNA feedback was identified as an important signaling pathway in keratinocyte senescence (35). Another study determined that the protective effect of baicalin on UVB-treated keratinocytes was mediated by miRNA expression modulation (36), indicating that miRNAs have important roles in keratinocyte proliferation. Therefore, our miRNA-based study regarding keratinocytes may provide important information regarding anti-UV therapeutics.

Zhou et al (19) recently characterized the miRNA profile in UVB-irradiated normal human keratinocytes. Interestingly, they displayed that miR-296-5p and miR-423-5p were down-regulated and upregulated by UVB irradiation (30 mJ/cm2, for 4 and 24 h) respectively. We found that the expression levels of these miRNAs showed the opposite responses to C. asiatica treatment; miR-296-5p was significantly increased by 2.54-fold and miR-423-5p was decreased by 1.65-fold. These results indicate that these miRNAs may be novel C. asiatica target miRNAs that protect keratinocytes against UVB-induced damage.

The miRNA target prediction and GO analysis revealed that a number of the target genes were involved in the apoptosis and cell proliferation pathways. MAPK-mediated signaling pathways are reportedly involved in UVB responses in keratinocytes (1). However, our data demonstrated that the target genes were less involved in MAPK-related signal transduction, suggesting that miRNA-based UVB protection pathways in keratinocytes may be mediated via anti-apoptosis and positive regulation of cell growth pathways, rather than through a MAPK pathway. In fact, although UV irradiation increases phosphorylation-mediated activation of MAPK proteins, including p38 MAPK, JNK and ERK1/2, the transcription and translation levels of these proteins are not altered by UVB irradiation (1), indicating that the MAPK genes do not interplay with C. asiatica-specific miRNAs involved in protecting keratinocytes from UVB-induced damage.

In conclusion, our findings suggest that C. asiatica-mediated protective mechanisms are mediated by alterations in miRNA expression. Although further confirmative studies are required to verify miRNA alterations and their putative targets, these data provide meaningful information to further our understanding of the cellular responses in TECA-mediated UVB protection in human keratinocytes.

We are grateful to the members of our research group for their support and advice regarding this study. This study was supported by the Ministry of Education, Science and Technology (grant 20110028646 to S.A.) of the Republic of Korea.

 References MuthusamyVPivaTJThe UV response of the skin: a review of the MAPK, NFkappaB and TNFalpha signal transduction pathwaysArch Dermatol Res3025172010 ClydesdaleGJDandieGWMullerHKUltraviolet light induced injury: immunological and inflammatory effectsImmunol Cell Biol795475682001 BenderKGottlicherMWhitesideSRahmsdorfHJHerrlichPSequential DNA damage-independent and -dependent activation of NF-kappaB by UVEMBO J17517051811998 LewisDASpandauDFUVB activation of NF-kappaB in normal human keratinocytes occurs via a unique mechanismArch Dermatol Res299931012007 LiNKarinMIonizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanismsProc Natl Acad Sci USA9513012130171998 YuanZQFeldmanRISunMInhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial CellsJ Biol Chem27729973299822002 LiuJYangDMinemotoYLeitgesMRosnerMRLinANF-kappaB is required for UV-induced JNK activation via induction of PKCdeltaMol Cell214674802006 KimHKangJSLeeWJThe production IL-21 and VEGF in UVB-irradiated human keratinocyte cell line, HaCaTImmune Netw1075802010 ChangDSSeoSJHongCKThe effect of amniotic membrane extract on the expression of iNOS mRNA and generation of NO in HaCaT cell by ultraviolet B irradiationPhotodermatol Photoimmunol Photomed182802862002 AmbrosVLeeRCIdentification of microRNAs and other tiny noncoding RNAs by cDNA cloningMethods Mol Biol2651311582004 ChengAMByromMWSheltonJFordLPAntisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosisNucleic Acids Res33129012972005 ChenJFMandelEMThomsonJMThe role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiationNat Genet382282332006 ChoWJShinJMKimJSmiR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2Mol Cells285215272009 HolstLMKaczkowskiBGniadeckiRReproducible pattern of microRNA in normal human skinExp Dermatol19e201e2052010 HolstLMKaczkowskiBGludMFutoma-KazmierczakEHansenLFGniadeckiRThe microRNA molecular signature of atypic and common acquired melanocytic nevi: differential expression of miR-125b and let-7cExp Dermatol202782802011 IchiharaAJinninMYamaneKmicroRNA-mediated keratinocyte hyperproliferation in Psoriasis vulgarisBr J Dermatol165100310102011 XuNBrodinPWeiTMiR-125b, a microRNA down-regulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2J Invest Dermatol131152115292011 HildebrandJRutzeMWalzNA comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivoJ Invest Dermatol13120292011 ZhouBRXuYPermatasariFCharacterization of the miRNA profile in UVB-irradiated normal human keratinocytesExp Dermatol213173192012 BrinkhausBLindnerMSchuppanDHahnEGChemical, pharmacological and clinical profile of the East Asian medical plant Centella asiaticaPhytomedicine74274482000 MaquartFXChastangFSimeonABirembautPGilleryPWegrowskiYTriterpenes from Centella asiatica stimulate extracellular matrix accumulation in rat experimental woundsEur J Dermatol92892961999 JayashreeGKurup MuraleedharaGSudarslalSJacobVBAnti-oxidant activity of Centella asiatica on lymphoma-bearing miceFitoterapia744314342003 BabuTDKuttanGPadikkalaJCytotoxic and anti-tumour properties of certain taxa of Umbelliferae with special reference to Centella asiatica (L.) UrbanJ Ethnopharmacol4853571995 KimYJChaHJNamKHYoonYLeeHAnSCentella asiatica extracts modulate hydrogen peroxide-induced senescence in human dermal fibroblastsExp Dermatol2099810032011 HashimPSidekHHelanMHSaberyAPalanisamyUDIlhamMTriterpene composition and bioactivities of Centella asiaticaMolecules16131013222011 PillaiRSBhattacharyyaSNFilipowiczWRepression of protein synthesis by miRNAs: how many mechanisms?Trends Cell Biol171181262007 LuLYingKWeiSAsiaticoside induction for cell-cycle progression, proliferation and collagen synthesis in human dermal fibroblastsInt J Dermatol438018072004 GuoJSChengCLKooMWInhibitory effects of Centella asiatica water extract and asiaticoside on inducible nitric oxide synthase during gastric ulcer healing in ratsPlanta Med70115011542004 ParkBCBosireKOLeeESLeeYSKimJAAsiatic acid induces apoptosis in SK-MEL-2 human melanoma cellsCancer Lett21881902005 BabykuttySPadikkalaJSathiadevanPPApoptosis induction of Centella asiatica on human breast cancer cellsAfr J Tradit Complement Altern Med69162008 LinLTLiuLTChiangLCLinCCIn vitro anti-hepatoma activity of fifteen natural medicines from CanadaPhytother Res164404442002 YoshidaMFuchigamiMNagaoTAntiproliferative constituents from Umbelliferae plants VIIActive triterpenes and rosmarinic acid from Centella asiatica Biol Pharm Bull281731752005 SampsonJHRamanAKarlsenGNavsariaHLeighIMIn vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponinsPhytomedicine82302352001 RuszymahBHChowdhurySRMananNAFongOSAdenanMISaimABAqueous extract of Centella asiatica promotes corneal epithelium wound healing in vitroJ Ethnopharmacol1403333382012 Rivetti di Val CervoPLenaAMNicolosoMp63-microRNA feedback in keratinocyte senescenceProc Natl Acad Sci USA109113311382012 XuYZhouBWuDiYinZLuoDBaicalin modulates microRNA expression in UVB irradiated mouse skinJ Biomed Res261251342012 Figures and Tables

Cytotoxic and UVB protective activities of TECA in HaCaT keratinocytes. (A) Cytotoxicity assay. HaCaT cells (4×103) were seeded on 96-well plates, and TECA was applied for 24 h as indicated. The cellular toxicity was measured using a WST-1 assay. The results are representative of 3 independent experiments (means ± SD are shown). (B) UVB protective activity of TECA in HaCaT cells. The graph represents the means ± SD of relative cell viability in each sample from triplicate experiments. For both assays, Student’s t-tests were performed to assess statistical significance (*p<0.05 compared with the control).

Analysis of TECA-induced miRNA expression profiles in UVB-irradiated HaCaT cells. (A) TECA induced both the upregulation and downregulation of miRNA expression levels. miRNAs with >1.5-fold expression changes were selected for further analysis. Red and blue bars indicate increased and decreased expression, respectively. (B) The number of miRNAs altered by >1.5-fold by TECA treatment in UVB-irradiated HaCaT cells.

Gene Ontology (GO)-based categorization of miRNA-target genes. The y-axis values display the number of genes involved in each of the processes listed on the right.

miRNAs altered by TECA treatment in UVB-exposed HaCaT keratinocytes.

miR name FC Chromosome miR name FC Chromosome
ebv-miR-BHRF1-1 1.57 - hsa-miR-636 3.51 Chr17
hsa-let-7b* 1.53 Chr22 hsa-miR-664 1.54 Chr1
hsa-let-7f-1 1.59 Chr9 hsa-miR-767-3p 1.56 ChrX
hsa-miR-1225-3p 1.70 Chr16 hsa-miR-92b 1.71 Chr1
hsa-miR-1227 1.57 Chr19 hsa-miR-933 1.63 Chr2
hsa-miR-1228 1.55 Chr12 hsv1-miR-H6-3p 1.61 -
hsa-miR-1234 1.66 Chr8 hsv1-miR-H7* 1.65 -
hsa-miR-1237 1.54 Chr11 hsv1-miR-H20 1.61 -
hsa-miR-1238 1.58 Chr19 hsv1-miR-H7-3p 1.66 -
hsa-miR-129* 1.61 Chr7 kshv-miR-K12-8* 1.63 -
hsa-miR-1470 1.80 Chr8 hsa-miR-192 −1.78 Chr11
hsa-miR-1539 1.62 Chr18 hsa-miR-182 −1.84 Chr7
hsa-miR-1825 1.66 Chr20 hsa-miR-210 −2.06 Chr11
hsa-miR-18b* 1.55 ChrX hsa-miR-132 −2.00 Chr17
hsa-miR-191* 1.53 Chr3 hsa-miR-9* −2.08 Chr1
hsa-miR-2116* 1.59 Chr15 hsa-miR-125a-5p −1.53 Chr19
hsa-miR-223 1.64 ChrX hsa-miR-155 −1.58 Chr21
hsa-miR-296-5p 2.54 Chr20 hsa-miR-99b −1.80 Chr19
hsa-miR-3180-5p 1.72 Chr16 hsa-miR-362-5p −1.72 ChrX
hsa-miR-33b* 1.54 Chr17 hsa-miR-374a −1.54 ChrX
hsa-miR-3613-3p 1.52 Chr13 hsa-miR-494 −1.53 Chr14
hsa-miR-3614-5p 1.61 Chr17 hsa-miR-181d −1.70 Chr19
hsa-miR-3620 3.60 Chr1 hsa-miR-532-5p −2.07 ChrX
hsa-miR-3675-3p 1.78 Chr1 hsa-miR-455-5p −2.07 Chr9
hsa-miR-3676 1.53 Chr17 hsa-miR-622 −2.82 Chr13
hsa-miR-3679-3p 1.54 Chr2 hsa-miR-625 −1.65 Chr14
hsa-miR-3940 1.77 Chr19 hsa-miR-660 −1.63 ChrX
hsa-miR-423-3p 2.04 Chr17 ebv-miR-7-1* −1.53 -
hsa-miR-425* 1.59 Chr3 hsa-miR-7-1* −1.88 Chr9
hsa-miR-4274 1.61 Chr4 hsa-miR-181a-2* −1.51 Chr9
hsa-miR-4310 1.52 Chr15 hsa-miR-140-3p −1.56 Chr16
hsa-miR-4313 1.58 Chr15 hsa-miR-362-3p −2.06 ChrX
hsa-miR-4323 1.62 Chr19 hsa-miR-423-5p −1.65 Chr17
hsa-miR-550a 1.51 Chr17 hsa-miR-483-5p −1.54 Chr11
hsa-miR-602 1.57 Chr9 hsa-miR-3652 −1.78 Chr12
hsa-miR-634 1.69 Chr17

The list shows miRNAs exhibiting a >1.5-fold expression change after flag sorting. FC, fold change.

Predicted target genes of the miRNAs upregulated in response to TECA treatment in UVB-exposed HaCaT keratinocytes.

Target gene functions
miRNA Aging Apoptosis Cell proliferation Skin development
hsa-miR-1228 TP53 TP53, CEBPG, PLAGL2, TJP1 TP53, ATP8A2, CD47, MKI67, SSTR1 -
hsa-miR-1237 ID2 BCL6, ERBB3, PAK7, ANKRD13C, SGPL1, UBE2Z ID2, BCL6, ERBB3, PAK7, NFIB, CCND2 -
hsa-miR-1825 SERPINE1, ULK3 SERPINE1, ITCH, OSR1, CECR2, PREX1, ROCK1, TIAM1, BCL11B, GPI, MITF, PKN2 SERPINE1, ITCH, OSR1, CHRNB2, EPS15, HHIP, KIT, MAB21L1, R3H1, FOXO4, BCL11B, MITF COL5A3, BCL11B
hsa-miR-223 F3, RPS6KB1 F3, RPS6KB1, APC, FGFR2, FOXO1, FOXO3, IGF1R, ECT2, ATP7A, HSP90B1, NLRP3, RASA1, RHOB, RNF34, SNCA, SYNGAP1 F3, RPS6KBI, APC, FGFR2, FOXO1, FOXO3, IGF1R, ACVR2A, CBLB, MYH10, PDS5B, SCARB1, WDR77, NFIB APC, ATP7A
hsa-miR-296-5p BBC3, HMGA1, PRELP BBC3, CNTFR, FGFR1, NUAK2, MEF2D HMGA1, CNTFR, FGFR1, CXCL10, MLL2 -
hsa-miR-550a CDK6, TERF2 ARHGEF12, MTDH, PSME1, UNC5A, SOX4 CDK6, APPL2, PDGFRA, TRIM27, SOX4, SOX11 -
hsa-miR-634 P2RY2, TGFBR1 ADRB2, ERBB4, VAV3, CSDA, IAPP, NEUROD1, RASSF5, YWHAE, KCNMA1, TGFBR1, KPNA1, MAP3K1, BLOC1S2, PDCD6IP ADRB2, ERBB4, VAV3, CKS1B, FOXP2, GOLPH3, INSR, JAG1, CCND2, TGFBR1, FBXW7, TBC1D8, EVI1, SSR1 -
hsa-miR-636 SOCS3 TCF7L2, RPS6KA2, SFRP2, TGFBR2, TRAF5, ACTN1, ARF6, GRIK2, ITSN1, PCGF2, PROC, RPS6KA3, RTN3, CBL, SENP1, YWHAZ, SOCS3, MITF, PKN2, PRKCE TCF7L2, RPS6KA2, SFRP2, TGFBR2, TRAF5, BCAT1, EMX2, LIFR, RNF139, MITF, TOB1 TCF7L2
hsa-miR-664 - CUL3, ZMYND11, BMX, C1D, CYCS, NET1, PDPK1, TAF9, TNFAIP1, UBE2D3, PAX3 CUL3, ZMYND11, ACSL6, BAP1, CDC14A, MTCP1, SMAD4, IRF2, PHOX2B, PAX3, FOXO4 -
hsa-miR-767-3p AGT, HTR2A AGT, CSNK2A1, CSNK2A2, HSPA9, SET, TRAF7, UBE2B, BLOC1S2, PDCD6IP AGT, HTR2A, ASPH, CDC25C, FGF7, JARID2, MLXIPL, NPR1,PDPN, PTCH1, ST8SIA1, TENC1, TIMP2, UBR5, BLOC1S2, CNOT8, EVI1, SSR1 -
hsa-miR-92b ADRB1, MORC3, NOX4, HCN2, PTEN ADRB1, APPL1, BTG2, GPI, CDK5R1, HAND2, ITGAV, KLF4, PTPRJ, SGK3, USP28, ARHGEF17, BCL2L11, DYRK2, FXR1, HIPK3, ITGA6, LYST, MAP2K4, NR4A3, RAD21, ROBO2, TRAF3, PTEN, SOX4, DAB2IP, BCL11B, PAX3 MORC3, NOX4, APPL1, BTG2, CDK5R1, HAND2, ITGAV, KLF4, BMPR2, EVI5, CDC27, CDCA7L, TSC1, CHRM5, CDKN1C, SGK3, FOSL2, PTPRJ, CXCL5, GATA2, GDF11, MS4A2, NKX2-3, PTPRU, S1PR1, TACC2, TGIF1, TOB2, DAB2IP, ZEB2, PTEN, ODZ1, BCL11B, SOX4, SOX11, PAX3 COL1A2, BCL11B

Predicted target genes of the miRNAs downregulated in response to TECA treatment in UVB-exposed HaCaT keratinocytes.

Target gene functions
miRNA Aging Apoptosis Cell proliferation Skin development
hsa-miR-192 SMC5 DICER1, GDNF DICER1, EREG -
hsa-miR-182 TMEM115, RTN4 RTN4, CITED2, EGR3, MEF2C, BCL2L13, ELMO1, NF1, MLL, ARHGEF3, BCL2L12, CREB1, MITF, SOX2, AATK, ACVR1, RAC1, TNFAIP8, TOX3 TMEM115, CITED2, NF1, EGR3, MEF2C, TNFSF11, MITF, SOX2, CBFA2T3, EVI1, MTSS1, PYGO2, CDV3, TOB1, FGF9 -
hsa-miR-132 CTGF FOXO3, MAPT, APAF1, RB1, SYNGAP1, MAPK3, CTGF ZEB2, FOXO3, HBEGF, CTGF, RB1, SPRY1 -
hsa-miR-125a-5p BAK1, VDR, CASP2, MAPK14 SGPL1, SYVN1, TAF9N, TIAF1, BAK1, VDR, CASP2, MAPK2, IER3IP1, KCNIP3, MYO18A, TRIAP1, MCL1, MAP3K11, SSTR3, ECE1, HK2, APC, BCL11B, COL4A3, IL6R, BCL11B, COL4A3, GPC4, BCAT1, CDH5, CGREF1, CYP27B1, DIS3L2, LIPA, BAK1, VDR, APC,IL6R, PRDM1, ENPEP, ESRRA, FBW4, TNFAIP3, MAP3K11, TNFSF4S COL4A3, BCL11B, APC
hsa-miR-155 FOS MAP3K10, RPS6KA3, VAV3, NKX3-1, TRIM32, MEF2A, PHF17, PKN2, SGK3, CBL, TP53INP1, YWHAZ NKX3-1, TRIM32, VAV3, SMAD2, SMAD1, SGK3, CSF1R, FGF7, JARID2 GNAS
hsa-miR-374a CCL2, ADRB1, WRN, WNT16 NTF3, PDPK1, PSMF1, SMAD6, CEBPB, NMT1, FGFR2, TGFA, DUSP6, EDAR, SOX4, WNT5A, ABR, CCL2, ADRB1, WRN, AKT1, BMP2, IL10, MSX1, MAP2K4, MEF2D, WNT5A, ADAM10, CD47, NCK1, PELI1, IL10, ING1, NUMB, CEBPB, FGFR2, ASCL1, BMP2, CNOT8, DLG3, EIF2S2, TFDP1, HES1, MMP14, CCL2, WNT16, AKT1, PITX2, TGFA, NR2F2, SOX4, -
hsa-miR-494 PTEN, BBC3, CHEK2, CNR1, SLC1A2, SIRT1 PTEN, BBC3, CHEK2, CNR1, CLI3, IL12B, KLF11, ACVR1C, GULP1, MTDH, PPARGC1A, ROCK1, UACA, IGF1R PTEN, GLI3, IL12B, NFIB, TACC2, IGF1R, DNAJA2, KLF11, CKS1B, GPNMB, PBRM1, EVI5, RAP1B, HHIP, SIRT1 LIF -
hsa-miR-181d ATM, PRKCD, SERPINE1, TGFBR1, ADRBK1, TIMP3 NOTCH2, PAWR, SRPK2, TNF, BAG4, CBX4, CCNG1, DDIT4, PRKCD, SERPINE1, TGFBR1, ATM, RAD21, RNF34, BMP7, GATA6, HEY2, IL1A, INSL3, ITSN1, HSP90B1, TNFAIP1, TRIM22, USP47 ATM, PRKCD, SERPINE1, TNF, CBLB, CDON, ING5, CARD11, GATA6, HEY2, INSL3, NOTCH2, PAWR, PLAU, PRDM4, PROX1, TGFBR1, BIRC6, IL1A, RBBP7, TNS3 -
hsa-miR-532-5p NUAK1 HSPA9, MED1, MBD4, IRS2, LEP, CAPN3, CYC5, EYA2 LEP, NDP, PURA, SKAP2, MED1, DDX11, IRS2, KRAS, FRS2 -
hsa-miR-622 NPM1 NPM1, APPL1, E2F1, PPARD, SATB1, BTK, SORT1, RARG, DYRK2 PPARD, SATB1 FBXW7, RXRB, TGIF1, RARG, NPM1, APPL1, E2F1, SALL1, MBD2 -
hsa-miR-625 - GHRH, IGF1, ISL1 GHRH, ARIH2, HOXD13, SPARC, IGF1, ISL1 -
hsa-miR-660 - TFAP2B, CDH13, HIPK1 TFAP2B, CDH13, LIFR TFAP2B